Secondary hemophagocytic lymphohistiocytosis and severe sepsis/systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation

Pediatric Critical Care Medicine

Volumn 10, Issue 3, 2009, Pages 387-392

  Castillo, Leticia ^a,b   Carcillo, Joseph ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b U S DEPARTMENT OF AGRICULTURE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Hemophagocytic lymphohistiocytosis; Macrophage activation syndrome; Multiorgan dysfunction syndrome; Sepsis; Systemic inflammatory response syndrome

Indexed keywords

ANTIBIOTIC AGENT; SOLUBLE INTERLEUKIN 2 RECEPTOR;

BONE MARROW TRANSPLANTATION; CELL ACTIVITY; CHEMOTHERAPY; CYTOPENIA; CYTOTOXIC LYMPHOCYTE; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; ERYTHROPHAGOCYTOSIS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; HYPERFERRITINEMIA; HYPERTRIGLYCERIDEMIA; HYPOFIBRINOGENEMIA; MACROPHAGE ACTIVATION SYNDROME; MORTALITY; MULTIPLE ORGAN FAILURE; NATURAL KILLER CELL; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SEPSIS; SEPTIC SHOCK; SPLENOMEGALY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ARTICLE; MACROPHAGE ACTIVATION;

HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MACROPHAGE ACTIVATION; MULTIPLE ORGAN FAILURE; PHENOTYPE; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 68849131525     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3181a1ae08     Document Type: Article

References (92)

1. Janka GE: Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 1983; 140: 221-230
2. Janka GE: Hemophagocytic syndromes. Blood Rev 2007; 21:245-253
3. Larroche C, Mouthon L: Pathogenesis of hemophagocytic syndrome (HPS). Autoimmun Rev 2004; 3:69-75
4. Imashuku S: Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 2002; 44:259-272 (Pubitemid 35435291)
5. Sato S, Kawashima H, Oshiro H, et al: Viro-logical and immunological characteristics of a 19-year-old Japanese female with fatal outcome with Epstein-Barr virus-associated he-mophagocytic syndrome. J Clin Virol 2004; 31:235-238
6. Hsieh SM, Chang SC: Insufficient perforin expression in CD8- T cells in response to hemagglutinin from avian influenza (H5N1) virus. J Immunol 2006; 176:4530-4533
7. Aleem A, Al Amoudi S, Al Mashhadani S, et al: Haemophagocytic syndrome associated with hepatitis-B virus infection responding to etoposide. Clin Lab Haematol 2005; 27: 395-398
8. Akamatsu N, Sugawara Y, Tamura S, et al: Hemophagocytic syndrome after adult-to-adult living donor liver transplantation. Transplant Proc 2006; 38:1425-1428 (Pubitemid 43912739)
9. Sun HY, Chen MY, Fang CT, et al: Hemophagocytic lymphohistiocytosis: An unusual initial presentation of acute HIV infection. J Acquir Immune Defic Syndr 2004; 37: 1539-1540
10. Mou SS, Nakagawa TA, Riemer EC, et al: Hemophagocytic lymphohistiocytosis complicating influenza A infection. Pediatrics 2006; 118:e216-e219
11. Ito S, Takada N, Ozasa A, et al: Secondary hemophagocytic syndrome in a patient with methicillin-sensitive Staphylococcus aureus bacteremia due to severe decubitus ulcer. Intern Med 2006; 45:303-307
12. El Khoury N, Lassoued K, Pelle G, et al: Hemophagocytosis associated with an Esch-erichia coli sepsis: A case report. Rev Med Interne 2003; 24:688-691
13. Brastianos PK, Swanson JW, Torbenson M, et al: Tuberculosis-associated haemophagocytic syndrome. Lancet Infect Dis 2006; 6: 447-454
14. Koduri PR, Chundi V, DeMarais P, et al: Reactive hemophagocytic syndrome: A new presentation of disseminated histoplasmosis in patients with AIDS. Clin Infect Dis 1995; 21:1463-1465
15. Agarwal S, Narayan S, Sharma S, et al: He-mophagocytic syndrome associated with visceral leishmaniasis. Indian J Pediatr 2006; 73:445-446
16. Saribeyoglu ET, Anak S, Agaoglu L, et al: Secondary hemophagocytic lymphohistiocytosis induced by malaria infection in a child with Langerhans cell histiocytosis. Pediatr Hematol Oncol 2004; 21:267-272
17. Sreedharan A, Bowyer S, Wallace CA, et al: Macrophage activation syndrome and other systemic inflammatory conditions after BMT. Bone Marrow Transplant 2006; 37:629-634
18. Arlet JB, Le TH, Marinho A, et al: Reactive haemophagocytic syndrome in adult-onset Still's disease: A report of six patients and a review of the literature. Ann Rheum Dis 2006; 65:1596-1601
19. Abdallah M, B'chir HS, Bouslama K, et al: Acute pancreatitis associated with hemoph-agocytic syndrome in systemic lupus ery-thematous: A case report. Gastroenterol Clin Biol 2005; 29:1054-1056
20. Kaneko K, Matsuda M, Sekijima Y, et al: Acute respiratory distress syndrome due to systemic lupus erythematosus with hemoph-agocytic syndrome: An autopsy report. Clin Rheumatol 2005; 24:158-161
21. al-Eid W, al-Jefri A, Bahabri S, et al: Hemophagocytosis complicating Kawasaki disease. Pediatr Hematol Oncol 2000; 17: 323-329
22. Henter JI, Horne A, Arico M, et al: HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48:124-131
23. Ramanan AV, Schneider R: Macrophage activation syndrome-What's in a name! J Rheu-matol 2003; 30:2513-2516
24. Grom AA: Macrophage activation syndrome and reactive hemophagocytic lymphohistio-cytosis: The same entities? Curr Opin Rheu-matol 2003; 15:587-590
25. Stabile A, Bertoni B, Ansuini V, et al: The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age. Eur Rev Med Pharmacol Sci 2006; 10:53-59
26. Arico M, Janka G, Fischer A, et al: Hemoph-agocytic lymphohistiocytosis. Report of 122 children from the International Registry FHL Study Group of the Histiocyte Society. Leukemia 1996; 10:197-203
27. Arico M, Danesino C, Pende D, et al: Patho-genesis of haemophagocytic lymphohistiocy-tosis. Br J Haematol 2001; 114:761-769
28. Henter JI, Elinder G, Ost A: Diagnostic guidelines for hemophagocytic lymphohis-tiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991; 18:29-33
29. Feldmann J, Callebaut I, Raposo G, et al: Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemoph-agocytic lymphohistiocytosis (FHL3). Cell 2003; 115:461-473
30. Yamamoto K, Ishii E, Horiuchi H, et al: Mutations of syntaxin 11 and SNAP23 genes as causes of familial hemophagocytic lymphohistiocytosis were not found in Japanese people. J Hum Genet 2005; 50:600-603
31. Goyette RE, Key NS, Ely EW: Hematologic changes in sepsis and their therapeutic implications. Semin Respir Crit Care Med 2004; 25:645-659
32. Voves C, Wuillemin WA, Zeerleder S: International Society on Thrombosis and Haemo-stasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients. Blood Coagul Fibrinolysis 2006; 17:445-451
33. Samra JS, Summers LK, Frayn KN: Sepsis and fat metabolism. Br J Surg 1996; 83: 1186-1196
34. Wendel M, Paul R, Heller AR: Lipoproteins in inflammation and sepsis. II. Clinical aspects. Intensive Care Med 2007; 33:25-35
35. Crouser ED, Julian MW, Huff JE, et al: A proteomic analysis of liver mitochondria during acute endotoxemia. Intensive Care Med 2006; 32:1252-1262
36. Wolfe RR: Substrate utilization/insulin resistance in sepsis/trauma. Baillieres Clin Endocrinol Metab 1997; 11:645-657
37. Murch O, Collin M, Hinds CJ, et al: Lipoproteins in inflammation and sepsis. I. Basic science. Intensive Care Med 2007; 33:13-24
38. Strauss R, Neureiter D, Westenburger B, et al: Multifactorial risk analysis of bone marrow histiocytic hyperplasia with hemophago-cytosis in critically ill medical patients-A postmortem clinicopathologic analysis. Crit Care Med 2004; 32:1316-1321
39. Schaer DJ, Schaer CA, Schoedon G, et al: Hemophagocytic macrophages constitute a major compartment of heme oxygenase expression in sepsis. Eur J Haematol 2006; 77:432-436
40. Kuwata K, Yamada S, Kinuwaki E, et al: Peripheral hemophagocytosis: An early indicator of advanced systemic inflammatory response syndrome/ hemophagocytic syndrome. Shock 2006; 25:344-350
41. Gauvin F, Toledano B, Champagne J, et al: Reactive hemophagocytic syndrome presenting as a component of multiple organ dysfunction syndrome. Crit Care Med 2000; 28: 3341-3345
42. Sharkey RA, Donnelly SC, Connelly KG, et al: Initial serum ferritin levels in patients with multiple trauma and the subsequent development of acute respiratory distress syndrome. Am J Respir Crit Care Med 1999; 159:1506-1509
43. Allen CE, Yu X, Kozinetz CA, et al: Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pedi-atr Blood Cancer 2008; 50:1227-1235
44. Sezer S, Ozdemir FN, Guz G, et al: Ferritin levels can be a good predictor for HCV vire-mia in potential renal transplant candidates. Transplant Proc 2001; 33:2796-2798
45. Moller HJ, Moestrup SK, Weis N, et al: Mac-rophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163. Crit Care Med 2006; 34:2561-2566
46. Abraham NG, Drummond G: CD163-Mediated hemoglobin-heme uptake activates macrophage HO-1, providing an antiinflam-matory function. Circ Res 2006; 99:911-914
47. Otterbein LE, Soares MP, Yamashita K, et al: Heme oxygenase-1: Unleashing the protective properties of heme. Trends Immunol 2003; 24:449-455
48. Berberat PO, Katori M, Kaczmarek E, et al: Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. FASEB J 2003; 17: 1724-1726
49. Bleesing J, Prada A, Siegel DM, et al: The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum 2007; 56: 965-971
50. Takala A, Jousela I, Takkunen O, et al: A prospective study of inflammation markers in patients at risk of indirect acute lung injury. Shock 2002; 17:252-257
51. Weiss M, Schneider EM: Soluble CD163: An age-dependent, anti-inflammatory biomar-ker predicting outcome in sepsis. Crit Care Med 2006; 34:2682-2683
52. Takala A, Jousela I, Jansson SE, et al: Markers of systemic inflammation predicting organ failure in community-acquired septic shock. Clin Sci (Lond) 1999; 97:529-538
53. Platz KP, Mueller AR, Rossaint R, et al: Cy-tokine pattern during rejection and infection after liver transplantation-Improvements in postoperative monitoring? Transplantation 1996; 62:1441-1450
54. Santana RC, Garcia-Munoz F, Reyes D, et al: Role of cytokines (interleukin-1beta, 6, 8, tumour necrosis factor-alpha, and soluble receptor of interleukin-2) and C-reactive protein in the diagnosis of neonatal sepsis. Acta Paediatr 2003; 92:221-227
55. Puente J, Miranda D, Gaggero A, et al: Immunological defects in septic shock. Defi-ciency of natural killer cells and T-lymphocytes. Rev Med Chil 1991; 119:142-146
56. Puente J, Carvajal T, Parra S, et al: In vitro studies of natural killer cell activity in septic shock patients. Response to a challenge with alpha-interferon and interleukin-2. Int J Clin Pharmacol Ther Toxicol 1993; 31:271-275 (Pubitemid 23187443)
57. Grom AA, Villanueva J, Lee S, et al: Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pe-diatr 2003; 142:292-296
58. Blazar BA, Rodrick ML, O'Mahony JB, et al: Suppression of natural killer-cell function in humans following thermal and traumatic injury. J Clin Immunol 1986; 6:26-36
59. el Sameea ER, Metwally SS, Mashhour E, et al: Evaluation of natural killer cells as diagnostic markers of early onset neonatal sepsis: Comparison with C-reactive protein and in-terleukin-8. Egypt J Immunol 2004; 11: 91-102
60. Janka GE, Schneider EM: Modern management of children with haemophagocytic lym-phohistiocytosis. Br J Haematol 2004; 124: 4-14
61. Henter JI, Samuelsson-Horne A, Arico M, et al: Treatment of hemophagocytic lymphohis-tiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002; 100:2367-2373
62. Imashuku S, Teramura T, Tauchi H, et al: Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Haematologica 2004; 89:183-188
63. Imashuku S: Etoposide-related secondary acute myeloid leukemia (t-AML) in hemoph-agocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48:121-123
64. Seo YI, Park R, Choi TY, et al: A case of therapy-related acute monocytic leukemia following low-dose of etoposide treatment for hemophagocytic lymphohistiocytosis. Korean J Lab Med 2007; 27:244-247
65. Sung L, King SM, Carcao M, et al: Adverse outcomes in primary hemophagocytic lym-phohistiocytosis. J Pediatr Hematol Oncol 2002; 24:550-554
66. Matsumoto Y, Naniwa D, Banno S, et al: The efficacy of therapeutic plasmapheresis for the treatment of fatal hemophagocytic syndrome: Two case reports. Ther Apher 1998; 2:300-304
67. Satomi A, Nagai S, Nagai T, et al: Effect of plasma exchange on refractory hemophago-cytic syndrome complicated with myelodys-plastic syndrome. Ther Apher 1999; 3:317-319
68. Estlin EJ, Palmer RD, Windebank KP, et al: Successful treatment of non-familial hae-mophagocytic lymphohistiocytosis with interferon and gammaglobulin. Arch Dis Child 1996; 75:432-435
69. Chen RL, Lin KH, Lin DT, et al: Immuno- modulation treatment for childhood virus-associated haemophagocytic lymphohistiocy-tosis. Br J Haematol 1995; 89:282-290
70. Cuhaci B: Plasma exchange in multiple organ failure: Changing gears in sepsis and organ failure. Crit Care Med 2003; 31: 1875-1877
71. Hampson FG, Hancock SW, Primhak RA: Disseminated sepsis due to a Panton-Valentine leukocidin producing strain of community acquired methicillin resistant Staphylococcus aureus and use of intravenous immunoglobulin therapy. Arch Dis Child 2006; 91:201
72. Linenberger ML, Price TH: Use of cellular and plasma apheresis in the critically ill patient: Part II: Clinical indications and applications. J Intensive Care Med 2005; 20: 88-103
73. Nguyen TC, Stegmayr B, Busund R, et al: Plasma therapies in thrombotic syndromes. Int J Artif Organs 2005; 28:459-465
74. Stegmayr BG, Banga R, Berggren L, et al: Plasma exchange as rescue therapy in multiple organ failure including acute renal failure. Crit Care Med 2003; 31:1730-1736
75. Kutko MC, Calarco MP, Flaherty MB, et al: Mortality rates in pediatric septic shock with and without multiple organ system failure. Pediatr Crit Care Med 2003; 4:333-337
76. Odetola FO, Gebremariam A, Freed GL: Patient and hospital correlates of clinical outcomes and resource utilization in severe pediatric sepsis. Pediatrics 2007; 119:487-494
77. Cortis E, Insalaco A: Macrophage activation syndrome in juvenile idiopathic arthritis. Acta Paediatr Suppl 2006; 95:38-41
78. Voskoboinik I, Smyth MJ, Trapani JA: Per-forin-mediated target-cell death and immune homeostasis. Nat Rev Immunol 2006; 6:940-952
79. Voskoboinik I, Trapani JA: Addressing the mysteries of perforin function. Immunol Cell Biol 2006; 84:66-71
80. van Dommelen SL, Sumaria N, Schreiber RD, et al: Perforin and granzymes have distinct roles in defensive immunity and immu-nopathology. Immunity 2006; 25:835-848
81. Pipkin ME, Lieberman J: Delivering the kiss of death: Progress on understanding how perforin works. Curr Opin Immunol 2007; 19:301-308
82. Chang YH, Lee DS, Jo HS, et al: Tumor necrosis factor alpha promoter polymorphism associated with increased susceptibility to secondary hemophagocytic lymphohis-tiocytosis in the Korean population. Cytokine 2006; 36:45-50
83. Rucevic M, Fast LD, Jay GD, et al: Altered levels and molecular forms of granzyme k in plasma from septic patients. Shock 2007; 27: 488-493
84. Zeerleder S, Hack CE, Caliezi C, et al: Activated cytotoxic T cells and NK cells in severe sepsis and septic shock and their role in multiple organ dysfunction. Clin Immunol 2005; 116:158-165
85. Hashimoto S, Kobayashi A, Kooguchi K, et al: Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome. Am J Respir Crit Care Med 2000; 161:237-243
86. Doughty L, Clark RS, Kaplan SS, et al: sFas and sFas ligand and pediatric sepsis-induced multiple organ failure syndrome. Pediatr Res 2002; 52:922-927
87. Yamada K, Yamamoto Y, Uchiyama A, et al: Successful treatment of neonatal herpes simplex-type 1 infection complicated by he-mophagocytic lymphohistiocytosis and acute liver failure. Tohoku J Exp Med 2008; 214: 1-5
88. Hot A, Madoux MH, Viard JP, et al: Successful treatment of cytomegalovirus-associated hemophagocytic syndrome by intravenous immunoglobulins. Am J Hematol 2008; 83: 159-162
89. Larroche C, Bruneel F, Andre MH, et al: Intravenously administered gamma-globulins in reactive hemaphagocytic syndrome. Multicenter study to assess their importance, by the immunoglobulins group of experts of CEDIT of the AP-HP. Ann Med In-terne (Paris) 2000; 151:533-539
90. Fort DW, Buchanan GR: Treatment of infection-associated hemophagocytic syndrome with immune globulin. J Pediatr 1994; 124: 332
91. Arico M, Allen M, Brusa S, et al: Haemoph-agocytic lymphohistiocytosis: Proposal of a diagnostic algorithm based on perforin expression. Br J Haematol 2002; 119: 180-188
92. Jordan MB: A series of unfortunate events. Blood 2005; 105:1372-1373